"name","description","molecule_smiles","molecule_iracema_id","source_doi","laboratory","institution","organism","target","parameters_value","parameters_unit"
"IC50","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(N)=S)C1=O","IRA-1","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","34 ± 1","μM ± SD"
"IC50","Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(N)=S)C1=O","IRA-1","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","28 ± 1","μM ± SD"
"%inhibition","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(N)=S)C1=O","IRA-1","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","83.0 ± 1.0","% ± SD"
"%inhibition","Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(N)=S)C1=O","IRA-1","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","82.0 ± 2.0","% ± SD"
"IC50","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(=O)c2ccccn2)C1=O","IRA-2","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","33 ± 2","μM ± SD"
"IC50","Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(=O)c2ccccn2)C1=O","IRA-2","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","20 ± 1","μM ± SD"
"%inhibition","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(=O)c2ccccn2)C1=O","IRA-2","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","76.0 ± 2.0","% ± SD"
"%inhibition","Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","CC(C)=CCC1=C(O)c2ccccc2/C(=N/NC(=O)c2ccccn2)C1=O","IRA-2","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","87.0 ± 2.0","% ± SD"
"IC50","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","O=C1C=C(Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C(=O)c2ccccc21","IRA-3","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","6.3 ± 0.1","μM ± SD"
"IC50","Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","O=C1C=C(Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C(=O)c2ccccc21","IRA-3","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","1.8 ± 0.1","μM ± SD"
"%inhibition","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","O=C1C=C(Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C(=O)c2ccccc21","IRA-3","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","95.0 ± 1.0","% ± SD"
"%inhibition","Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","O=C1C=C(Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C(=O)c2ccccc21","IRA-3","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","93.0 ± 0.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease cysteine cruzain (CRZ), present in Trypanosoma cruzi","O=C(NNC1=CC(=O)c2ccccc2C1=O)c1ccncc1","IRA-4","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","37.0 ± 2.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","O=C(NNC1=CC(=O)c2ccccc2C1=O)c1ccncc1","IRA-4","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","37.0 ± 2.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease cysteine cruzain (CRZ), present in Trypanosoma cruzi","O=C1C=C(Nc2ccccc2)C(=O)c2ccccc21","IRA-5","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","48.0 ± 3.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","O=C1C=C(Nc2ccccc2)C(=O)c2ccccc21","IRA-5","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","61.0 ± 2.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease cysteine cruzain (CRZ), present in Trypanosoma cruzi","[CH2+]c1cc(NS(=O)(=O)c2ccc(NC3=CC(=O)c4ccccc4C3=O)cc2)no1","IRA-6","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","6.0 ± 2.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","[CH2+]c1cc(NS(=O)(=O)c2ccc(NC3=CC(=O)c4ccccc4C3=O)cc2)no1","IRA-6","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","1.0 ± 1.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease cysteine cruzain (CRZ), present in Trypanosoma cruzi","CC(NC1=CC(=O)c2ccccc2C1=O)c1ccccc1","IRA-7","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","26.0 ± 2.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","CC(NC1=CC(=O)c2ccccc2C1=O)c1ccccc1","IRA-7","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","23.0 ± 3.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease cysteine cruzain (CRZ), present in Trypanosoma cruzi","O=C1C=C(O)c2ccccc2/C1=N/NC(=O)c1ccncc1","IRA-8","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","66.0 ± 5.0","% ± SD"
"%inhibition","(Compound with activity only at 100 µM) Inhibition of the protease rhodesain (RhD), present in Trypanosoma brucei","O=C1C=C(O)c2ccccc2/C1=N/NC(=O)c1ccncc1","IRA-8","10.1016/j.bmc.2021.116213","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Rhodesain protease","52.0 ± 2.0","% ± SD"
"%inhibition","Inhibition of the E3-E2-E1 glycoprotein complex of the Chikungunya virus","O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccccc1","IRA-9","10.3390/ph13070141","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","E3-E2-E1 glycoproteins complex","49.1 ± 11.1","% ± SD"
"%inhibition","Inhibition of the E3-E2-E1 glycoprotein complex of the Chikungunya virus","O=C(/C=C/c1cccc(Cl)c1)Nc1ccccc1","IRA-10","10.3390/ph13070141","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","E3-E2-E1 glycoproteins complex","81.1 ± 6.4","% ± SD"
"%inhibition","Inhibition of the E3-E2-E1 glycoprotein complex of the Chikungunya virus","COc1ccccc1/C=C/C(=O)Nc1ccccc1","IRA-11","10.3390/ph13070141","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","E3-E2-E1 glycoproteins complex","32.2 ± 2.4","% ± SD"
"IC50","Inhibition of the nsP2 protease of the Chikungunya virus","O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccccc1","IRA-9","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease","12.50 ± 0.06","μM ± SD"
"EC50","Inhibition of the nsP2 protease of the Chikungunya virus","O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccccc1","IRA-9","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease"," 5.2 ± 0.52","μM ± SD"
"CC50","Cytotoxicity against Vero cells incubated with increasing concentrations of inhibitors of 50, 100, and 200 μM for specific determination of the CC50 for 24 or 48 hours, using the MTT assay","O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccccc1","IRA-9","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Vero cells","165.3 ± 2.68","μM ± SD"
"IC50","Inhibition of the nsP2 protease of the Chikungunya virus","O=C(/C=C/c1ccc(Cl)cc1Cl)Nc1ccccc1","IRA-12","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease","20 ± 2.90","μM ± SD"
"EC50","Inhibition of the nsP2 protease of the Chikungunya virus","O=C(/C=C/c1ccc(Cl)cc1Cl)Nc1ccccc1","IRA-12","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease","47.9 ± 8.82","μM ± SD"
"CC50","Cytotoxicity against Vero cells incubated with increasing concentrations of inhibitors of 50, 100, and 200 μM for specific determination of the CC50 for 24 or 48 hours, using the MTT assay","O=C(/C=C/c1ccc(Cl)cc1Cl)Nc1ccccc1","IRA-12","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Vero cells",">200","μM"
"IC50","Inhibition of the nsP2 protease of the Chikungunya virus","COc1ccccc1/C=C/C(=O)Nc1ccccc1","IRA-11","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease","0.95 ± 0.07","μM ± SD"
"EC50","Inhibition of the nsP2 protease of the Chikungunya virus","COc1ccccc1/C=C/C(=O)Nc1ccccc1","IRA-11","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease","25.9 ± 0.12","μM ± SD"
"CC50","Cytotoxicity against Vero cells incubated with increasing concentrations of inhibitors of 50, 100, and 200 μM for specific determination of the CC50 for 24 or 48 hours, using the MTT assay","COc1ccccc1/C=C/C(=O)Nc1ccccc1","IRA-11","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Vero cells",">200","μM"
"IC50","Inhibition of the nsP2 protease of the Chikungunya virus. Significantly cytotoxic after 48h at the lower tested concentration (50 μM) on Vero cells. Thus, this inhibitor was excluded from further investigations.","O=C(/C=C/c1ccc(Br)cc1)Nc1ccccc1","IRA-13","10.1016/j.ejmech.2023.115572","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Chikungunya virus","nsP2 protease","15.2 ± 0.15","μM ± SD"
"IC50","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","COc1cccc2cc(/C(C)=N/NC(N)=S)c(=O)oc12","IRA-14","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","14.4 ± 0.02","μM ± SD"
"IC50","Inhibition of the cysteine protease cathepsin L-like enzyme (TbrCATL), present in Trypanosoma brucei","COc1cccc2cc(/C(C)=N/NC(N)=S)c(=O)oc12","IRA-14","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Cathepsin L-like cysteine protease","2.0 ± 0.6","μM ± SD"
"EC50","Inhibitor of the Trypanosoma cruzi trypomastigotes","COc1cccc2cc(/C(C)=N/NC(N)=S)c(=O)oc12","IRA-14","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Trypomastigotes","5.5","μM"
"EC50","Inhibitor of the Trypanosoma brucei trypomastigotes","CN(C)c1ccc(/C=C/C(=O)c2cc3ccccc3oc2=O)cc1","IRA-15","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Trypomastigotes","4.8 ± 0.15","μM ± SD"
"%inhibition","Inhibitor of the Trypanosoma brucei trypomastigotes","CN(C)c1ccc(/C=C/C(=O)c2cc3ccccc3oc2=O)cc1","IRA-15","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Prostaglandin F2α synthase","98","%"
"IC50","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","O=C(NCCO)c1cc2cc([N+](=O)[O-])ccc2oc1=O","IRA-16","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","79.9 ± 8.6","μM ± SD"
"IC50","Inhibition of the cysteine protease cathepsin L-like enzyme (TbrCATL), present in Trypanosoma brucei","O=C(NCCO)c1cc2cc([N+](=O)[O-])ccc2oc1=O","IRA-16","10.1039/d2nj04946e","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma brucei","Cathepsin L-like cysteine protease","84.7 ± 5.77","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","C/C(=N\NC(N)=S)c1cc2ccc(O)cc2oc1=O","IRA-17","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","42,16 ± 5,16","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","CN(C)c1ccc(/C=C/C(=O)c2cc3ccccc3oc2=O)cc1","IRA-15","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","72,40 ± 6,53","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","CC(=O)c1cc2ccc(O)cc2oc1=O","IRA-18","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","86,72 ± 7,29","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","COc1cccc2cc(/C(C)=N/NC(N)=S)c(=O)oc12","IRA-14","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","89,75 ± 4,14","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","C/C(=N\NC(N)=O)c1cc2ccc(O)cc2oc1=O","IRA-19","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","112.79 ± 4.64","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","CN(C)c1ccc(/C=N/NC(=O)c2cc3ccccc3oc2=O)cc1","IRA-20","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","158.65 ± 14.63","μM ± SD"
"IC50","Inhibition of the enzyme tyrosinase, involved in the biosynthesis of melanin in humans","COC(=O)c1cc2ccccc2oc1=O","IRA-21","10.3390/ijms24065216","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Human","Tyrosinase","155.68 ± 17.43","μM ± SD"
"IC50","Inhibition of the Trypanosoma cruzi intracellular amastigotes","CC(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCCC2","IRA-22","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","8.78","μM"
"%inhibition","Inhibition of the Trypanosoma cruzi intracellular amastigotes","CC(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCCC2","IRA-22","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","59.64","%"
"IC50","Inhibition of the Trypanosoma cruzi intracellular amastigotes","CC(C)OC(=O)c1c(/N=C2\SCC(=O)N2c2ccccc2)sc2c1CCCC2","IRA-23","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","6.96","μM"
"%inhibition","Inhibition of the Trypanosoma cruzi intracellular amastigotes","CC(C)OC(=O)c1c(/N=C2\SCC(=O)N2c2ccccc2)sc2c1CCCC2","IRA-23","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","39.44","%"
"IC50","Inhibition of the Trypanosoma cruzi intracellular amastigotes","CC(C)OC(=O)c1c(/N=c2\scc(-c3ccccc3)n2-c2ccccc2)sc2c1CCCC2","IRA-24","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","6.03","μM"
"%inhibition","Inhibition of the Trypanosoma cruzi intracellular amastigotes","CC(C)OC(=O)c1c(/N=c2\scc(-c3ccccc3)n2-c2ccccc2)sc2c1CCCC2","IRA-24","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","59.52","%"
"IC50","Inhibition of the Trypanosoma cruzi intracellular amastigotes","C=CCn1c(-c2ccccc2)cs/c1=N\c1sc2c(c1C(=O)OCC)CCCC2","IRA-25","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","9.7","μM"
"%inhibition","Inhibition of the Trypanosoma cruzi intracellular amastigotes","C=CCn1c(-c2ccccc2)cs/c1=N\c1sc2c(c1C(=O)OCC)CCCC2","IRA-25","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Amastigotes","53.07","%"
"IC50","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","C=CCn1c(-c2ccccc2)cs/c1=N\c1sc2c(c1C(=O)OCC)CCCC2","IRA-25","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","2.4 ± 1.2","μM ± SD"
"%inhibition","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi. Value calculated with pre-incubation","C=CCn1c(-c2ccccc2)cs/c1=N\c1sc2c(c1C(=O)OCC)CCCC2","IRA-25","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","97 ± 0.3","% ± SD"
"%inhibition","Inhibition of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi. Value calculated without pre-incubation","C=CCn1c(-c2ccccc2)cs/c1=N\c1sc2c(c1C(=O)OCC)CCCC2","IRA-25","10.1016/j.bmc.2016.07.013","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Trypanosoma cruzi","Cruzain cysteine protease","87 ± 5","% ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","20.0 ± 1.3","μM ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","18.2 ± 1.0","μM ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","15.1 ± 0.9","% ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","7.79 ± 0.43","% ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","13.4 ± 0.9","μM ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","22.4 ± 2.0","μM ± SD"
"CC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex"," >200","μM"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","17.4 ± 1.2","μM ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","21.1 ± 1.4","μM ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","13.2 ± 0.8","% ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","9.03 ± 0.60","% ± SD"
"CC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex",">100","μM"
"EC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","35.1","μM"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","20.9 ± 2.6","μM ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","24.4 ± 2.4","μM ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","15.8 ± 2.0","% ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","10.4 ± 1.0","% ± SD"
"CC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex",">100","μM"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus. LQM474 was significantly cytotoxic at the lowest tested concentration (25μM) to Vero E6 cells. Therefore, further investigations were not performed for this compound","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","26.8 ± 2.8","μM ± SD"
"IC50","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","39.9 ± 2.4","μM ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Zika virus","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Zika virus","NS2B/NS3 serine protease complex","20.3 ± 2.1","% ± SD"
"%inhibition","Inhibition of the NS2B/NS3 serine protease complex, present in Dengue virus","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","Dengue virus","NS2B/NS3 serine protease complex","17.0 ± 1.0","% ± SD"
"%inhibition","Inhibition of the serine protease trypsin","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","80","%"
"IC50","Inhibition of the serine protease trypsin","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","12.1 ± 0.9","μM ± SD"
"%inhibition","Inhibition of the serine protease urokinase plasminogen activator (uPA)","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Urokinase plasminogen activator serine protease","31","%"
"%inhibition","Inhibition of the cysteine proteases cathepsin-L","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CNCc1ccccc1","IRA-26","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Cathepsin-L cysteine protease","33","%"
"%inhibition","Inhibition of the serine protease trypsin","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","54","%"
"IC50","Inhibition of the serine protease trypsin","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","30.2 ± 3.3","μM ± SD"
"%inhibition","Inhibition of the serine protease urokinase plasminogen activator (uPA)","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Urokinase plasminogen activator serine protease","27","%"
"%inhibition","Inhibition of the cysteine proteases cathepsin-L","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Cathepsin-L cysteine protease","57","%"
"IC50","Inhibition of the cysteine proteases cathepsin-L","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCSCC1","IRA-27","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Cathepsin-L cysteine protease","24.5 ± 2.3","μM ± SD"
"%inhibition","Inhibition of the serine protease trypsin","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","67","%"
"IC50","Inhibition of the serine protease trypsin","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","22.7 ± 2.2","μM ± SD"
"%inhibition","Inhibition of the serine protease urokinase plasminogen activator (uPA)","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Urokinase plasminogen activator serine protease","48","%"
"IC50","Inhibition of the serine protease urokinase plasminogen activator (uPA)","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Urokinase plasminogen activator serine protease","23.8 ± 2.0","μM ± SD"
"%inhibition","Inhibition of the cysteine proteases cathepsin-L","N#C/C(=C\c1ccc(-c2ccc(Cl)c(Cl)c2)o1)C(=O)CN1CCOCC1","IRA-28","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Cathepsin-L cysteine protease","29","%"
"%inhibition","Inhibition of the serine protease trypsin","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","74","%"
"IC50","Inhibition of the serine protease trypsin","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Trypsin serine protease","27.3 ± 3.1","μM ± SD"
"%inhibition","Inhibition of the serine protease urokinase plasminogen activator (uPA)","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Urokinase plasminogen activator serine protease","68","%"
"IC50","Inhibition of the serine protease urokinase plasminogen activator (uPA)","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Urokinase plasminogen activator serine protease","22.1 ± 2.9","μM ± SD"
"%inhibition","Inhibition of the cysteine proteases cathepsin-L","CN1CCN(CC(=O)/C(C#N)=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)CC1","IRA-29","10.1039/d2nj01983c","Institute of Chemistry and Biotechnology (IQB)","Federal University of Alagoas","","Cathepsin-L cysteine protease","32","%"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1cc(CNCc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-30","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1cc(CNCc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-30","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","67.19 ± 18.41","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1cc(CNCc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-30","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1cc(CNCc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-30","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1cc(CNCc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-30","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1cc(CNCc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-30","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-31","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","123.86 ± 32.20 ","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-31","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","73.71 ± 13.79 ","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","Cc1ccc(S(=O)(=O)N/N=C/c2cccs2)cc1","IRA-62","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","226.43 ± 0.024","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-31","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","152.60 ± 17.92","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-31","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-31","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-31","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-32","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","118.31 ± 17.90","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-32","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","92.31 ± 32.57 ","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-32","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-32","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-32","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1cc(C[N]Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-32","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1c(C[N]Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-33","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1c(C[N]Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-33","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","106.55 ± 16.87","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1c(C[N]Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-33","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1c(C[N]Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-33","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1c(C[N]Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-33","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1c(C[N]Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-33","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","COc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-34","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","COc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-34","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","COc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-34","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","COc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-34","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","COc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-34","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","COc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-34","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","Oc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-35","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","112.19 ± 23.18","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","Oc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-35","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","Oc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-35","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","Oc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-35","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","Oc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-35","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","Oc1ccc(CNCc2ccc3c(c2)OCO3)cc1O","IRA-35","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-36","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-36","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","91.18 ± 21.85","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-36","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-36","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-36","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1[2H]","IRA-36","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-37","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-37","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","76.42 ± 10.10","µM ± SD"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-37","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-37","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-37","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c([2H])c1OC","IRA-37","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-38","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-38","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-38","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-38","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-38","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1cc(CN(C)Cc2ccc3c(c2)OCO3)c([2H])c(OC)c1OC","IRA-38","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition on the cellular viability of A549, a lung tumor cell line adenocarcinoma","[2H]c1c(CN(C)Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-39","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","A549","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H1299, a non-small cell carcinoma","[2H]c1c(CN(C)Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-39","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H1299","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H292, a mucoepidermoid pulmonary carcinoma","[2H]c1c(CN(C)Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-39","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H292","> 200","µM"
"IC50","Inhibition on the cellular viability of NCI-H460, a non-small cell carcinoma","[2H]c1c(CN(C)Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-39","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","NCI-H460","> 200","µM"
"IC50","Inhibition on the cellular viability of HUVEC, a non tumorigenic cells","[2H]c1c(CN(C)Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-39","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","HUVEC","> 200","µM"
"IC50","Inhibition on the cellular viability of LL24, a human lung fibroblast cells","[2H]c1c(CN(C)Cc2ccc3c(c2)OCO3)cc(OC)c(OC)c1OC","IRA-39","10.1016/j.bmc.2016.07.065","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","LL24","> 200","µM"
"IC50","Inhibition of the epimastigotes forms of Trypanosoma cruzi (No toxicity until 50 µM)","N=C(N)NN=Cc1ccc[nH]1","IRA-40","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Epimastigotes","139.45","µM "
"%inhibition","Inhibition of the CL14 strain of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi (No toxicity until 50 µM)","N=C(N)NN=Cc1ccc[nH]1","IRA-40","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Cruzain cysteine protease","10 ± 3","µM ± SD"
"IC50","Inhibition of the epimastigotes forms of Trypanosoma cruzi (No toxicity until 50 µM)","NC(=S)N/N=C/c1ccc[nH]1","IRA-41","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Epimastigotes","27.0","µM "
"%inhibition","Inhibition of the CL14 strain of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi (No toxicity until 50 µM)","NC(=S)N/N=C/c1ccc[nH]1","IRA-41","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Cruzain cysteine protease ","70 ± 8","µM ± SD"
"IC50","Inhibition of the epimastigotes forms of Trypanosoma cruzi","NC(=O)N/N=C/c1ccc[nH]1","IRA-42","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Epimastigotes",">2","µM "
"%inhibition","Inhibition of the CL14 strain of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","NC(=O)N/N=C/c1ccc[nH]1","IRA-42","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Cruzain cysteine protease ","10 ± 3","µM ± SD"
"%inhibition","Inhibition of the CL14 strain of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","CN(C)c1ccc(/C=N/NC(=N)N)cc1","IRA-43","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Cruzain cysteine protease ","55 ± 4","µM ± SD"
"IC50","Inhibition of the epimastigotes forms of Trypanosoma cruzi (No toxicity until 250 μM)","CN(C)c1ccc(C=NNC(N)=S)cc1","IRA-44","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Epimastigotes","19.8","µM "
"%inhibition","Inhibition of the CL14 strain of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi (No toxicity until 250 μM)","CN(C)c1ccc(C=NNC(N)=S)cc1","IRA-44","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Cruzain cysteine protease ","70 + 7 ","µM ± SD"
"IC50","Inhibition of the epimastigotes forms of Trypanosoma cruzi","CN(C)c1ccc(C=NNC(N)=O)cc1","IRA-45","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Epimastigotes",">2","µM "
"%inhibition","Inhibition of the CL14 strain of the cysteine protease cruzain (CRZ), present in Trypanosoma cruzi","CN(C)c1ccc(C=NNC(N)=O)cc1","IRA-45","10.1080/07391102.2016.1176603","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Trypanosoma cruzi","Cruzain cysteine protease ","75 ± 8","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","CC(C)(C)c1ccc(S(=O)(=O)N/N=C/c2ccc3c(c2)OCO3)cc1","IRA-46","10.2174/1570180815666180321161513","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","MCF-7","142.4","µM"
"IC50","Induces apoptosis in MDA-MB-231 Human Triple-negative Breast Cancer. Modeling aggressive and resistant cancer","CC(C)(C)c1ccc(S(=O)(=O)N/N=C/c2ccc3c(c2)OCO3)cc1","IRA-46","10.2174/1570180815666180321161513","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","MDA-MB-231","104.6","µM"
"IC50","Induces apoptosis in 3T3 Mouse Normal Fibroblast Toxicity Control (non-cancerous)","CC(C)(C)c1ccc(S(=O)(=O)N/N=C/c2ccc3c(c2)OCO3)cc1","IRA-46","10.2174/1570180815666180321161513","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Mouse","3T3","165.9","µM"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","COc1cc(/C=N/NS(=O)(=O)c2ccc(C(C)(C)C)cc2)ccc1O","IRA-47","10.2174/1570180815666180321161513","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","MCF-7","144.6 ","µM"
"IC50","Induces apoptosis in MDA-MB-231 Human Triple-negative Breast Cancer. Modeling aggressive and resistant cancer","COc1cc(/C=N/NS(=O)(=O)c2ccc(C(C)(C)C)cc2)ccc1O","IRA-47","10.2174/1570180815666180321161513","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Human","MDA-MB-231","173.2 ","µM"
"IC50","Induces apoptosis in 3T3 Mouse Normal Fibroblast Toxicity Control (non-cancerous)","COc1cc(/C=N/NS(=O)(=O)c2ccc(C(C)(C)C)cc2)ccc1O","IRA-47","10.2174/1570180815666180321161513","Laboratório de Planejamento e Síntese de Substâncias Bioativas (LAPESSB)","University of São Paulo ","Mouse","3T3","108.4","µM"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","[2H]c1ccc(C(O)CNC([2H])([2H])c2ccccc2)cc1","IRA-48","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","209.60 ± 3.10","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","[2H]c1ccc(C(O)CNC([2H])([2H])c2ccccc2)cc1","IRA-48","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","225.30 ± 3.85","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","[2H]c1ccc(C(O)CNC([2H])([2H])c2ccccc2)cc1","IRA-48","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","201.60 ± 4.45","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","OC(CNCCc1ccccc1)c1ccccc1","IRA-49","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","318.50 ± 0.45","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","OC(CNCCc1ccccc1)c1ccccc1","IRA-49","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","189.90 ± 5.9 ","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","OC(CNCCc1ccccc1)c1ccccc1","IRA-49","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","197.50 ± 5.40","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","OC(CNCCCc1ccccc1)c1ccccc1","IRA-50","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","96.40 ± 2.77","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","OC(CNCCCc1ccccc1)c1ccccc1","IRA-50","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","101.80 ± 1.79","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","OC(CNCCCc1ccccc1)c1ccccc1","IRA-50","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","195.60 ± 0.75","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","OC(CNCCCCc1ccccc1)c1ccccc1","IRA-51","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","37.17 ± 1.34","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","OC(CNCCCCc1ccccc1)c1ccccc1","IRA-51","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","50.76 ± 2.47","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","OC(CNCCCCc1ccccc1)c1ccccc1","IRA-51","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","107.30 ± 4.7","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","CC(C)(C)NCC(O)c1ccccc1","IRA-52","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","279.60 ± 1.5","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","CC(C)(C)NCC(O)c1ccccc1","IRA-52","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","259.40 ± 4.17","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","CC(C)(C)NCC(O)c1ccccc1","IRA-52","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","187.70 ± 5.76","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","OC(CNCCCCc1ccccc1)c1ccc(Br)cc1","IRA-53","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","14.48 ± 0.61","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","OC(CNCCCCc1ccccc1)c1ccc(Br)cc1","IRA-53","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","22.71 ± 0.21","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","OC(CNCCCCc1ccccc1)c1ccc(Br)cc1","IRA-53","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","58.54 ± 1.33","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","OC(CNCc1ccccc1)c1ccc(Br)cc1","IRA-54","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","53.01 ± 2.66","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","OC(CNCc1ccccc1)c1ccc(Br)cc1","IRA-54","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","73.89 ± 3.12","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","OC(CNCc1ccccc1)c1ccc(Br)cc1","IRA-54","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","115.60 ± 0.95","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","OC(CNc1ccccc1)c1ccccc1","IRA-55","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","236.20 ± 5.35","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","OC(CNc1ccccc1)c1ccccc1","IRA-55","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","236.90 ± 4.92","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","OC(CNc1ccccc1)c1ccccc1","IRA-55","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","316.60 ± 4.85","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","c1ccc(CN2CC2c2ccccc2)cc1","IRA-56","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","27.83 ± 0.42","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","c1ccc(CN2CC2c2ccccc2)cc1","IRA-56","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","40.42 ± 1.34","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","c1ccc(CN2CC2c2ccccc2)cc1","IRA-56","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","40.99 ± 0.25","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","c1ccc(CCN2CC2c2ccccc2)cc1","IRA-57","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","169.70 ± 5.99","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","c1ccc(CCN2CC2c2ccccc2)cc1","IRA-57","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","19.00 ± 0.90","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","c1ccc(CCN2CC2c2ccccc2)cc1","IRA-57","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","37.57 ± 1.5","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","c1ccc(CCCN2CC2c2ccccc2)cc1","IRA-58","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","24.50 ± 1.11","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","c1ccc(CCCN2CC2c2ccccc2)cc1","IRA-58","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","19.89 ± 2.23","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","c1ccc(CCCN2CC2c2ccccc2)cc1","IRA-58","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","35.43 ± 1.31","µM ± SD"
"IC50","Induces apoptosis in MCF-7 Human Breast Cancer cell in addition to Hormone Therapy Trials","c1ccc(CCCCN2CC2c2ccccc2)cc1","IRA-59","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-7","24.72 ± 0.05","µM ± SD"
"IC50","Induces apoptosis in MDA-MB-231 Human triple negative breast cancer cell","c1ccc(CCCCN2CC2c2ccccc2)cc1","IRA-59","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MDA-MB-231","11.09 ± 0.39","µM ± SD"
"CC50","Cytotoxicity against MCF-10, a healthy breast cell line","c1ccc(CCCCN2CC2c2ccccc2)cc1","IRA-59","10.1016/j.ejmech.2018.07.055","Center for Research and Advancements in Fragments and Molecular Targets (CRAFT)","University of São Paulo","Human","MCF-10","43.30 ± 0.03","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccco2)cc1","IRA-60","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.1 ± 0.04","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccco2)cc1","IRA-60","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.21 ± 0.016","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","Cc1ccc(S(=O)(=O)N/N=C/c2ccco2)cc1","IRA-60","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","239.25 ± 0.06","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","Cc1ccc(S(=O)(=O)NN=Cc2ccc([N+](=O)[O-])o2)cc1","IRA-61","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.092 ± 0.019","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","Cc1ccc(S(=O)(=O)NN=Cc2ccc([N+](=O)[O-])o2)cc1","IRA-61","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.12 ± 0.012","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","Cc1ccc(S(=O)(=O)NN=Cc2ccc([N+](=O)[O-])o2)cc1","IRA-61","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","300.99 ± 0.021","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","Cc1ccc(S(=O)(=O)N/N=C/c2cccs2)cc1","IRA-62","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.089 ± 0.038","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1","IRA-63","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.085 ± 0.023","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","Cc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1","IRA-63","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","133.48 ± 0.025","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccc[nH]2)cc1","IRA-64","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccc[nH]2)cc1","IRA-64","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccc(N(C)C)cc2)cc1","IRA-65","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","2.24 ± 0.01","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","Cc1ccc(S(=O)(=O)N/N=C/c2ccc(N(C)C)cc2)cc1","IRA-65","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.89 ± 0.023","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","Cc1ccc(S(=O)(=O)N/N=C/c2ccc(N(C)C)cc2)cc1","IRA-65","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","211.08 ± 0.019","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1ccco1","IRA-66","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1ccco1","IRA-66","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1cccs1","IRA-67","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","4.67 ± 0.06","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1cccs1","IRA-67","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.79 ± 0.037","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1cccs1","IRA-67","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","167.47 ± 0.029","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1ccc2c(c1)OCO2","IRA-68","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1ccc2c(c1)OCO2","IRA-68","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","O=S(=O)(N/N=C/c1ccco1)c1ccc(Cl)cc1","IRA-69","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.14 ± 0.028","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","O=S(=O)(N/N=C/c1ccco1)c1ccc(Cl)cc1","IRA-69","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.86 ± 0.013","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","O=S(=O)(N/N=C/c1ccco1)c1ccc(Cl)cc1","IRA-69","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","322.05 ± 0.024","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","O=[N+]([O-])c1ccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)o1","IRA-70","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.094 ± 0.09","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","O=[N+]([O-])c1ccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)o1","IRA-70","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","293.17 ± 0.013","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","O=S(=O)(N/N=C/c1cccs1)c1ccc(Cl)cc1","IRA-71","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","O=S(=O)(N/N=C/c1cccs1)c1ccc(Cl)cc1","IRA-71","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","O=[N+]([O-])c1ccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)s1","IRA-72","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.080 ± 0.01","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","O=[N+]([O-])c1ccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)s1","IRA-72","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.33 ± 0.09","µM ± SD"
"IC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","O=[N+]([O-])c1ccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)s1","IRA-72","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","246.00 ± 0.19","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","O=S(=O)(N/N=C/c1ccc[nH]1)c1ccc(Cl)cc1","IRA-73","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","1.14 ± 0.049","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","O=S(=O)(N/N=C/c1ccc[nH]1)c1ccc(Cl)cc1","IRA-73","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","87.79 ± 0,058","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CN(C)c1ccc(C=NNS(=O)(=O)c2ccc(Cl)cc2)cc1","IRA-74","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","3.12 ± 0.09","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CN(C)c1ccc(C=NNS(=O)(=O)c2ccc(Cl)cc2)cc1","IRA-74","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","2.78 ± 0.047","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CN(C)c1ccc(C=NNS(=O)(=O)c2ccc(Cl)cc2)cc1","IRA-74","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","87.62 ± 0.037","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1ccco1","IRA-75","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","2.94 ± 0.029","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1ccco1","IRA-75","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","204.79 ± 0.027","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1cccs1","IRA-76","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","4.92 ± 0.016","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1cccs1","IRA-76","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","2.13 ± 0.067","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1cccs1","IRA-76","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","283.09 ± 0.081","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1ccc2c(c1)OCO2","IRA-77","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.47 ± 0.03","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1ccc2c(c1)OCO2","IRA-77","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.91 ± 0.02","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","C/C(=N\NS(=O)(=O)c1ccc(Cl)cc1)c1ccc2c(c1)OCO2","IRA-77","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","209.44 ± 0.056","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccco2)cc1","IRA-78","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.42 ± 0.047","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccco2)cc1","IRA-78","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","161.96 ± 0.019","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])o2)cc1","IRA-79","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.39 ± 0.065","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])o2)cc1","IRA-79","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","283.02 ± 0.029","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2cccs2)cc1","IRA-80","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2cccs2)cc1","IRA-80","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1","IRA-81","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.092 ± 0.015","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1","IRA-81","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.97 ± 0.079","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1","IRA-81","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","248.51 ± 0.017","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc[nH]2)cc1","IRA-82","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.91 ± 0.5","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc[nH]2)cc1","IRA-82","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","211.53 ± 0.039","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc(N(C)C)cc2)cc1","IRA-83","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2ccc(N(C)C)cc2)cc1","IRA-83","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2ccco2)cc1","IRA-84","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","1.34 ± 0.078","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2ccco2)cc1","IRA-84","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","183,94 ± 0.038","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2cccs2)cc1","IRA-85","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","4.27 ± 0.091","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2cccs2)cc1","IRA-85","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","1.16 ± 0.07","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2cccs2)cc1","IRA-85","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","212.73 ± 0.064","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2ccc3c(c2)OCO3)cc1","IRA-86","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","2.15 ± 0.017","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CC(=O)Nc1ccc(S(=O)(=O)N/N=C(\C)c2ccc3c(c2)OCO3)cc1","IRA-86","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","124.93 ± 0.018","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CS(=O)(=O)N/N=C/c1ccco1","IRA-87","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain",">10","µM"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CS(=O)(=O)N/N=C/c1ccco1","IRA-87","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain",">10","µM"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CS(=O)(=O)N/N=C/c1ccc([N+](=O)[O-])o1","IRA-88","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.23 ± 0.054","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CS(=O)(=O)N/N=C/c1ccc([N+](=O)[O-])o1","IRA-88","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.83 ± 0.078","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CS(=O)(=O)N/N=C/c1ccc([N+](=O)[O-])o1","IRA-88","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","107.88 ± 0.052","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CS(=O)(=O)N/N=C/c1cccs1","IRA-89","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.21 ± 0.054","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CS(=O)(=O)N/N=C/c1cccs1","IRA-89","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.48 ± 0.041","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CS(=O)(=O)N/N=C/c1cccs1","IRA-89","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","247.68 ± 0.024","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])s1","IRA-90","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.83 ± 0.034","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])s1","IRA-90","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","442.33 ± 0.093","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CCS(=O)(=O)N/N=C/c1ccco1","IRA-91","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.096 ± 0.060","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CCS(=O)(=O)N/N=C/c1ccco1","IRA-91","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.99 ± 0.059","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CCS(=O)(=O)N/N=C/c1ccco1","IRA-91","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","460.54 ± 0.056","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CCS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])o1","IRA-92","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.10 ± 0.08","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CCS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])o1","IRA-92","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.22 ± 0.038","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CCS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])o1","IRA-92","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","402.84 ± 1.7","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CCS(=O)(=O)N/N=C/c1cccs1","IRA-93","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.25 ± 0.023","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CCS(=O)(=O)N/N=C/c1cccs1","IRA-93","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.23 ± 0.049","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CCS(=O)(=O)N/N=C/c1cccs1","IRA-93","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","245.23 ± 0.016","µM ± SD"
"IC50","Inhibition of Plasmodium falciparum chloroquine-sensitive (3D7) strain","CCS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])s1","IRA-94","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","3D7 strain","0.12 ± 0.043","µM ± SD"
"IC50","Inhinition of Plasmodium falciparum chloroquine-resistant (W2) strain","CCS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])s1","IRA-94","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Plasmodium falciparum","W2 strain","0.19 ± 0.015","µM ± SD"
"LC50","Cytotoxicity against human lung fibrobast cell line (WI-26 VA4)","CCS(=O)(=O)NN=Cc1ccc([N+](=O)[O-])s1","IRA-94","10.4155/fmc-2020-0229","Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC) ","University of São Paulo ","Human","WI-26 VA4","122.50 ± 0.020","µM ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Oc1cccc2cccnc12","IRA-95","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","0.07 ± 0.02","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","Oc1cccc2cccnc12","IRA-95","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","6.08 ± 0.22","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Oc1cccc2cccnc12","IRA-95","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","15.47 ± 2.98","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Oc1ccc(Cl)c2cccnc12","IRA-96","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","0.27 ± 0.01","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","Oc1ccc(Cl)c2cccnc12","IRA-96","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","1.25 ± 0.02","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Oc1ccc(Cl)c2cccnc12","IRA-96","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","≥50","µg/mL"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Oc1c(Br)ccc2cccnc12","IRA-97","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","0.19 ± 0.09","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","Oc1c(Br)ccc2cccnc12","IRA-97","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","0.95 ± 0.03","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Oc1c(Br)ccc2cccnc12","IRA-97","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","11.02 ± 0.73","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Oc1c(I)cc(I)c2cccnc12","IRA-98","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote","7.01 ± 0.15","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Oc1c(I)cc(I)c2cccnc12","IRA-98","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","5.1 ± 0.12","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Oc1c(I)cc(Cl)c2cccnc12","IRA-99","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","5.95 ± 0.22","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","Oc1c(I)cc(Cl)c2cccnc12","IRA-99","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","2.81 ± 0.06","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Oc1c(I)cc(Cl)c2cccnc12","IRA-99","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","21.7 ± 1.43","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Oc1c(Br)cc(I)c2cccnc12","IRA-100","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","9.11 ± 0.19","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Oc1c(Br)cc(I)c2cccnc12","IRA-100","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","4.9 ± 0.31","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","COc1cccc2cccnc12","IRA-101","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","7.46 ± 0.53","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","COc1cccc2cccnc12","IRA-101","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","4.7 ± 0.21","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","COc1c(I)cc(I)c2cccnc12","IRA-102","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","9.51 ± 0.92","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","COc1c(I)cc(I)c2cccnc12","IRA-102","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","5.3 ± 0.11","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","COc1c(I)cc(Cl)c2cccnc12","IRA-103","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","9.02 ± 0.28","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","COc1c(I)cc(Cl)c2cccnc12","IRA-103","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","6.47 ± 0.39","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","COc1c(Br)cc(I)c2cccnc12","IRA-104","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","9.53 ± 1.04","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","COc1c(Br)cc(I)c2cccnc12","IRA-104","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","8.46 ± 0.61","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","c1ccc(COc2cccc3cccnc23)cc1","IRA-105","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","4.37 ± 0.62","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","c1ccc(COc2cccc3cccnc23)cc1","IRA-105","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","24.09 ± 1.75","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Ic1cc(I)c2cccnc2c1OCc1ccccc1","IRA-106","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","1.80 ± 0.69","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Ic1cc(I)c2cccnc2c1OCc1ccccc1","IRA-106","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages",">50","µg/mL"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Clc1cc(I)c(OCc2ccccc2)c2ncccc12","IRA-107","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","2.13 ± 0.26","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Clc1cc(I)c(OCc2ccccc2)c2ncccc12","IRA-107","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages",">50","µg/mL"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","Brc1cc(I)c2cccnc2c1OCc1ccccc1","IRA-108","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","2.45 ± 0.37","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","Brc1cc(I)c2cccnc2c1OCc1ccccc1","IRA-108","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages",">50","µg/mL"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","CC(=O)Oc1cccc2cccnc12","IRA-109","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","3.58 ± 0.33","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","CC(=O)Oc1cccc2cccnc12","IRA-109","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","12.48 ± 1.01","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","CC(=O)Oc1c(I)cc(I)c2cccnc12","IRA-110","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","2.59 ± 0.72","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","CC(=O)Oc1c(I)cc(I)c2cccnc12","IRA-110","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","16.05 ± 3.05","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","CC(=O)Oc1c(I)cc(Cl)c2cccnc12","IRA-111","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","2.82 ± 0.95","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","CC(=O)Oc1c(I)cc(Cl)c2cccnc12","IRA-111","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","1.84 ± 0.01","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","CC(=O)Oc1c(I)cc(Cl)c2cccnc12","IRA-111","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","15.09 ± 1.21","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","CC(=O)Oc1c(Br)cc(I)c2cccnc12","IRA-112","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","3.68 ± 0.10","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","CC(=O)Oc1c(Br)cc(I)c2cccnc12","IRA-112","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","0.46 ± 0.07","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","CC(=O)Oc1c(Br)cc(I)c2cccnc12","IRA-112","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","16.31 ± 0.92","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","O=C(Oc1cccc2cccnc12)c1ccccc1","IRA-113","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","6.83 ± 0.46","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","O=C(Oc1cccc2cccnc12)c1ccccc1","IRA-113","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","21.81 ± 1.54","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","O=C(Oc1c(I)cc(I)c2cccnc12)c1ccccc1","IRA-114","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","4.90 ± 1.04","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","O=C(Oc1c(I)cc(I)c2cccnc12)c1ccccc1","IRA-114","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","6.98 ± 0.93","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","O=C(Oc1c(I)cc(I)c2cccnc12)c1ccccc1","IRA-114","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","16.31 ± 3.03","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","O=C(Oc1c(I)cc(Cl)c2cccnc12)c1ccccc1","IRA-115","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","5.71 ± 0.52","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","O=C(Oc1c(I)cc(Cl)c2cccnc12)c1ccccc1","IRA-115","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","15.61 ± 1.33","µg/mL ± SD"
"EC50","Leishmanicidal activity against promastigote forms of Leishmania (Leishmania) amazonensis","O=C(Oc1c(Br)cc(I)c2cccnc12)c1ccccc1","IRA-116","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Promastigote ","4.47 ± 1.02","µg/mL ± SD"
"EC50","Leishmanicidal activity against amastigotes forms of Leishmania (Leishmania) amazonensis","O=C(Oc1c(Br)cc(I)c2cccnc12)c1ccccc1","IRA-116","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Leishmania(Leishmania) amazonensis","Amastigotes","13.45 ± 0.65","µg/mL ± SD"
"CC50","Cytotoxicity against human J774 macrophages cell line","O=C(Oc1c(Br)cc(I)c2cccnc12)c1ccccc1","IRA-116","10.4155/fmc-2018-0124","Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF)","Federal University of São Paulo","Human","J774 macrophages","22.10 ± 3.68","µg/mL ± SD"